Press Release
Press Release - Q1FY27
- Total Revenue INR 1,196 Cr, +36.1% YoY, +10.3% QoQ; EBITDA INR 240 Cr, +20.1% YoY, +10.9% QoQ
- EBITDA margin at 20.1% vs 22.7% Q1FY26 and 19.9% Q4FY26; PAT INR 37 Cr vs INR 85 Cr Q1FY26
- Consolidated Revenue from Operations INR 1,180 Cr, +35.3% YoY; EBITDA Pre-INDAS INR 206 Cr, +10.2% YoY
- ARPOB grew 9.7% YoY; IP volume +26.6% YoY; OP volume +28.5% YoY
- CMD: New hospital in Palakkad added; advanced procedures including lung transplants performed
- Group operates 26 hospitals with 8,300+ beds; plans to add 1,300+ beds
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 KIMS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add KIMS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Krishna Institute of Medical Sciences Limited
Important.
The summary above is generated automatically from Krishna Institute of Medical Sciences Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.